You are here

drug pricing

After protests, pharma industry reaches 'landmark' drug spending deal with UK government

After protests, pharma industry reaches 'landmark' drug spending deal with UK government

Fierce Pharma

Flag link:

Cigna's Express Scripts launches cost-based drug pricing model

Cigna's Express Scripts launches cost-based drug pricing model

Investing.com

Express Scripts

cost-based pricing

Flag link:

Senator floats new models to manage costs of weight loss drugs like Ozempic

Senator floats new models to manage costs of weight loss drugs like Ozempic

Stat

Flag link:

Bluebird won't play off Vertex in deciding price for its lovo-cel gene therapy, exec says

Bluebird won't play off Vertex in deciding price for its lovo-cel gene therapy, exec says

Fierce Pharma

Vertex Pharmaceuticals

sickle cell disease

Flag link:

Sen. Bernie Sanders moves toward another hearing with pharma CEOs

Sen. Bernie Sanders moves toward another hearing with pharma CEOs

Stat

Flag link:

Biogen-Sage Therapeutics postpartum depression pill priced at $15,900

Biogen-Sage Therapeutics postpartum depression pill priced at $15,900

Reuters

SAGE Therapeutics

postpartum depression

Flag link:

HHS Considers Removing J&J’s Stelara from Medicare Drug Price Negotiations

HHS Considers Removing J&J’s Stelara from Medicare Drug Price Negotiations

BioSpace

Inflation Reduction Act

Flag link:

Pfizer Will Charge Up To $1,400 For Covid Drug Paxlovid

Pfizer Will Charge Up To $1,400 For Covid Drug Paxlovid

Forbes

Flag link:

Lilly, AbbVie, BMS and more rally against UK's 'arbitrary' growth cap on branded drug market

Lilly, AbbVie, BMS and more rally against UK's 'arbitrary' growth cap on branded drug market

Fierce Pharma

Flag link:

Oncology Practices May Be Hurt by Medicare Drug Price Negotiations

Oncology Practices May Be Hurt by Medicare Drug Price Negotiations

OBR Oncology

Flag link:

Boehringer Ingelheim embraces dual-pricing tactic with launch of unbranded Humira biosimilar

Boehringer Ingelheim embraces dual-pricing tactic with launch of unbranded Humira biosimilar

Fierce Pharma

Boehringer Ingelheim

Flag link:

Drugmakers face uphill battle in Medicare negotiation suits

Drugmakers face uphill battle in Medicare negotiation suits

Pharma Voice

Inflation Reduction Act

Flag link:

US judge refuses to block Medicare from negotiating drug prices

US judge refuses to block Medicare from negotiating drug prices

Reuters

Inflation Reduction Act

Flag link:

Novo Nordisk challenges CMS drug price negotiations, then signs on to the program

Novo Nordisk challenges CMS drug price negotiations, then signs on to the program

Fierce Pharma

Inflation Reduction Act

Flag link:

Senator probes Cleveland Clinic, Bon Secours over 340B program

Senator probes Cleveland Clinic, Bon Secours over 340B program

Beckers Hospital Review

Cleveland Clinic

Flag link:

AstraZeneca, BMS Reluctantly Agree to Medicare Drug Price Negotiation Program

AstraZeneca, BMS Reluctantly Agree to Medicare Drug Price Negotiation Program

BioSpace

Bristol Myers Squibb

Inflation Reduction Act

Flag link:

The 340B Program Reached $54 Billion in 2022—Up 22% vs. 2021

The 340B Program Reached $54 Billion in 2022—Up 22% vs. 2021

Drug Channels

Flag link:

Revance rolls out a price drop for Daxxify as it tries to challenge AbbVie's Botox

Revance rolls out a price drop for Daxxify as it tries to challenge AbbVie's Botox

Fierce Pharma

Revance Therapeutics

Flag link:

DOJ, Chamber of Commerce Tussle in Court Over IRA’s Drug Price Negotiations

DOJ, Chamber of Commerce Tussle in Court Over IRA’s Drug Price Negotiations

BioSpace

Inflation Reduction Act

Flag link:

How Payers Are Reacting to Insulin Price Changes

How Payers Are Reacting to Insulin Price Changes

Drug Channels

Inflation Reduction Act

Flag link:

Pages